Mini review: The FDA-approved prescription drugs that induce ovulation in women with ovulatory problems

Drug Dev Res. 2020 Nov;81(7):815-822. doi: 10.1002/ddr.21687. Epub 2020 May 19.

Abstract

Infertility is defined as not being able to become pregnant after 12 months or more of unprotected sexual intercourse. Female infertility as a serious health issue can result from ovulation disorders, menstrual cycle problems, structural problems, and environmental factors. Ovulation occurs once a month between the time of menarche and menopause. The release of a mature egg from the ovary is controlled with the hypothalamic-pituitary-ovarian axis. Several hormones such as gonadotropin-releasing hormone (GnRH), FSH (follicle-stimulating hormone), LH (luteinizing hormone), estrogen, and progesterone play fundamental roles in the ovulation process. Both FSH and LH are the main treatment for women with ovulation disorders. Depending on the reasons for infertility, several different types of treatment are available for infertile women. Fertility drugs as an important part of treatment work like the natural hormones to treat infertility. Several fertility drugs can regulate ovulation and the release of an egg from the ovary in women with polycystic ovary syndrome (PCOS) or undergoing in vitro fertilization (IVF) treatment. This mini-review is about the FDA-approved prescription drugs that induce ovulation in women with ovulatory problems.

Keywords: FDA-approved drugs; in vitro fertilization; infertility; ovulation; polycystic ovary syndrome.

Publication types

  • Review

MeSH terms

  • Drug Approval
  • Female
  • Fertility Agents / therapeutic use*
  • Humans
  • Infertility, Female / drug therapy*
  • Ovulation / drug effects*
  • Prescription Drugs / therapeutic use
  • United States
  • United States Food and Drug Administration

Substances

  • Fertility Agents
  • Prescription Drugs